4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001104659-24-111031
President/CEO bought 500 shares at $3.92 ($1,958)
From the SEC's structured data for this filing
Trades in this filing
Gilad Oren · President/CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-10-23 | Purchase : show line 1 in the form | +500 | $3.92 | $1,958 | 333,395 | D |
| Open-market purchases · 500 sh · avg $3.92 · $1,958 | ||||||
Loading xslF345X05/tm2426748-1_4seq1.xml…